Published 27 October 2003. doi:10.1083/jcb.200303010
© The Rockefeller University Press,
0021-9525/2003/10/303 $8.00
The Journal of Cell Biology, Volume 163, Number 2, 303-314
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells
Silvia Parisi1,
Daniela D'Andrea1,
Carmine T. Lago1,
Eileen D. Adamson2,
M. Graziella Persico1 and
Gabriella Minchiotti1
1 Institute of Genetics and Biophysics, "Adriano Buzzati-Traverso," Consiglio Nazionale delle Ricerche, 80131 Naples, Italy
2 Cancer Research Center, The Burnham Institute, La Jolla, CA 92037
Address correspondence to Gabriella Minchiotti, Institute of Genetics and Biophysics, "A. Buzzati-Traverso," CNR Via Pietro Castellino 111, 80131 Naples, Italy. Tel.: 39-081-6132354. Fax: 39-081-6132595. email: minchiot{at}iigb.na.cnr.it
The molecular mechanisms controlling inductive events leading to the specification and terminal differentiation of cardiomyocytes are still largely unknown. We have investigated the role of Cripto, an EGF-CFC factor, in the earliest stages of cardiomyogenesis. We find that both the timing of initiation and the duration of Cripto signaling are crucial for priming differentiation of embryonic stem (ES) cells into cardiomyocytes, indicating that Cripto acts early to determine the cardiac fate. Furthermore, we show that failure to activate Cripto signaling in this early window of time results in a direct conversion of ES cells into a neural fate. Moreover, the induction of Cripto activates the Smad2 pathway, and overexpression of activated forms of type I receptor ActRIB compensates for the lack of Cripto signaling in promoting cardiomyogenesis. Finally, we show that Nodal antagonists inhibit Cripto-regulated cardiomyocyte induction and differentiation in ES cells. All together our findings provide evidence for a novel role of the Nodal/Cripto/Alk4 pathway in this process.
Key Words: Cripto; cardiomyocytes; neurons; differentiation; Nodal signaling
Abbreviations used in this paper: BMP, bone morphogenetic protein; ca, constitutively activated; Cerberus-S, Cerberus-Short; EB, embryoid body; ES, embryonic stem; HPRT, hypoxanthine phosphoribosyltransferase; MHC, myosin heavy chain; MLC, myosin light chain; wt, wild type.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Kelber, J. A., Shani, G., Booker, E. C., Vale, W. W., Gray, P. C.
(2008). Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and Nodal. J. Biol. Chem.
283: 4490-4500
[Abstract]
[Full Text]
-
D'Andrea, D., Liguori, G. L., Le Good, J. A., Lonardo, E., Andersson, O., Constam, D. B., Persico, M. G., Minchiotti, G.
(2008). Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction. J. Cell Biol.
180: 597-605
[Abstract]
[Full Text]
-
Watanabe, K., Hamada, S., Bianco, C., Mancino, M., Nagaoka, T., Gonzales, M., Bailly, V., Strizzi, L., Salomon, D. S.
(2007). Requirement of Glycosylphosphatidylinositol Anchor of Cripto-1 for trans Activity as a Nodal Co-receptor. J. Biol. Chem.
282: 35772-35786
[Abstract]
[Full Text]
-
Shi, S., Ge, C., Luo, Y., Hou, X., Haltiwanger, R. S., Stanley, P.
(2007). The Threonine That Carries Fucose, but Not Fucose, Is Required for Cripto to Facilitate Nodal Signaling. J. Biol. Chem.
282: 20133-20141
[Abstract]
[Full Text]
-
Kitamura, R., Takahashi, T., Nakajima, N., Isodono, K., Asada, S., Ueno, H., Ueyama, T., Yoshikawa, T., Matsubara, H., Oh, H.
(2007). Stage-Specific Role of Endogenous Smad2 Activation in Cardiomyogenesis of Embryonic Stem Cells. Circ. Res.
101: 78-87
[Abstract]
[Full Text]
-
Puceat, M.
(2007). TGF{beta} in the differentiation of embryonic stem cells. Cardiovasc Res
74: 256-261
[Abstract]
[Full Text]
-
Liu, Y., Asakura, M., Inoue, H., Nakamura, T., Sano, M., Niu, Z., Chen, M., Schwartz, R. J., Schneider, M. D.
(2007). Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. Proc. Natl. Acad. Sci. USA
104: 3859-3864
[Abstract]
[Full Text]
-
Hentschke, M., Kurth, I., Borgmeyer, U., Hubner, C. A.
(2006). Germ Cell Nuclear Factor Is a Repressor of CRIPTO-1 and CRIPTO-3. J. Biol. Chem.
281: 33497-33504
[Abstract]
[Full Text]
-
Gruen, L., Grabel, L.
(2006). Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy. Stem Cells
24: 2162-2169
[Abstract]
[Full Text]
-
Chu, J., Ding, J., Jeays-Ward, K., Price, S. M., Placzek, M., Shen, M. M.
(2005). Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis. Development
132: 5539-5551
[Abstract]
[Full Text]
-
Mishra, L., Derynck, R., Mishra, B.
(2005). Transforming Growth Factor-{beta} Signaling in Stem Cells and Cancer. Science
310: 68-71
[Abstract]
[Full Text]
-
Vallier, L., Alexander, M., Pedersen, R. A.
(2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci.
118: 4495-4509
[Abstract]
[Full Text]
-
Keller, G.
(2005). Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev.
19: 1129-1155
[Abstract]
[Full Text]
-
Wobus, A. M., Boheler, K. R.
(2005). Embryonic Stem Cells: Prospects for Developmental Biology and Cell Therapy. Physiol. Rev.
85: 635-678
[Abstract]
[Full Text]
-
Parish, C. L., Parisi, S., Persico, M. G., Arenas, E., Minchiotti, G.
(2005). Cripto as a Target for Improving Embryonic Stem Cell-Based Therapy in Parkinson's Disease. Stem Cells
23: 471-476
[Abstract]
[Full Text]
-
Foley, A. C., Mercola, M.
(2005). Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev.
19: 387-396
[Abstract]
[Full Text]
-
Dunn, N. R., Koonce, C. H., Anderson, D. C., Islam, A., Bikoff, E. K., Robertson, E. J.
(2005). Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile. Genes Dev.
19: 152-163
[Abstract]
[Full Text]
-
Paglialunga, F., Fico, A., Iaccarino, I., Notaro, R., Luzzatto, L., Martini, G., Filosa, S.
(2004). G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch. Blood
104: 3148-3152
[Abstract]
[Full Text]